New antihypertensive drugs;Neue antihypertensiva in sicht

MMW-Fortschritte der Medizin

Volumn 154, Issue 4, 2012, Pages 72-73

  Derer, Wolfgang ^a   Müller, Dominik N ^b   Dechend, Ralf ^c  

^a HELIOS KLINIKUM BERLIN BUCH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Angiotensin receptor blockade; Hypertension; Multifunctional antihypertensives; Renin inhibition

Indexed keywords

ANTIHYPERTENSIVE AGENT; NEW DRUG;

CONFERENCE PAPER; DRUG INDICATION; HUMAN; HYPERTENSION;

EID: 84858971237     PISSN: 14383276     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15006-012-0253-6     Document Type: Conference Paper

References (5)

1. 1. P. Balakumar M. Rose S.S. Ganti P. Krishan M. Singh 2007 PPAR dual agonists: are they opening Pandora’s Box? Pharmacol. Res. 56 2 91 8 17428674 10.1016/j.phrs.2007.03.002 1:CAS:528:DC%2BD2sXpvF2rtLk%3D Balakumar P, Rose M, Ganti SS, Krishan P, Singh M: PPAR dual agonists: are they opening Pandora’s Box? Pharmacol. Res.. 56, Nr. 2, August 2007, S. 91–8
2. 2. Sica D et al., 2011
3. 3. Bakris GL et al., 2011
4. 4. L.M. Ruilope A. Dukat M. Böhm Y. Lacourcière J. Gong M.P. Lefkowitz 2010 Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study Lancet 375 9722 1255 66 20236700 10.1016/S0140-6736(09)61966-8 1:CAS:528:DC%2BC3cXksFClsbw%3D Ruilope LM, Dukat A, Böhm M, Lacourcière Y, Gong J, Lefkowitz MP: Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study. Lancet 2010 Apr 10; 375 (9722) 1255–66
5. 5. A.C. Tissot P. Mauer J. Nussberger R. Sabat T. Pfister S. Ignatenko H.D. Volk H. Stocker P. Müller G.T. Jennings F. Wagner M.F. Bachmann 2008 Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study Lancet 371 9615 821 7 18328929 10.1016/S0140-6736(08)60381-5 1:CAS:528:DC%2BD1cXivFyqtbY%3D Tissot AC, Mauer P, Nussberger J, Sabat R, Pfister T, Ignatenko S, Volk HD, Stocker H, Müller P, Jennings GT, Wagner F, Bachmann MF: Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study. Lancet 2008, Mar 8; 371 (9615) 821–7